➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Johnson and Johnson
Boehringer Ingelheim
Baxter
Express Scripts

Last Updated: December 4, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Nitrazepam

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Nitrazepam?

Nitrazepam is an investigational drug.

There have been 4 clinical trials for Nitrazepam. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2015.

The most common disease conditions in clinical trials are Epilepsy, Anxiety Disorders, and Sleep Initiation and Maintenance Disorders. The leading clinical trial sponsors are Birmingham Children's Hospital NHS Foundation Trust, Matthew's Friends, and Alder Hey Children's NHS Foundation Trust.

There is one US patent protecting this investigational drug and ten international patents.

Recent Clinical Trials for Nitrazepam
TitleSponsorPhase
Ketogenic Diet in Infants With Epilepsy (KIWE)Alder Hey Children's NHS Foundation TrustPhase 4
Ketogenic Diet in Infants With Epilepsy (KIWE)Birmingham Children's Hospital NHS Foundation TrustPhase 4
Ketogenic Diet in Infants With Epilepsy (KIWE)Bristol Royal Hospital for ChildrenPhase 4

See all Nitrazepam clinical trials

Clinical Trial Summary for Nitrazepam

Top disease conditions for Nitrazepam
Top clinical trial sponsors for Nitrazepam

See all Nitrazepam clinical trials

US Patents for Nitrazepam

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nitrazepam   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Nitrazepam   Start Trial Methyl diazepane orexin receptor antagonists Merck Sharp & Dohme Corp. (Rahway, NJ)   Start Trial
Nitrazepam   Start Trial Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof   Start Trial
Nitrazepam   Start Trial Pyrazole, triazole and tetrazole orexin receptor antagonists Merck Sharp & Dohme Corp. (Rahway, NJ)   Start Trial
Nitrazepam   Start Trial Tamper-resistant pharmaceutical dosage forms and process for making same ExxPharma Therapeutics LLC (Morris Plains, NJ)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Nitrazepam

Drugname Country Document Number Estimated Expiration Related US Patent
Nitrazepam Canada CA2961033 2034-09-11   Start Trial
Nitrazepam European Patent Office EP3192791 2034-09-11   Start Trial
Nitrazepam Japan JPWO2016039408 2034-09-11   Start Trial
Nitrazepam World Intellectual Property Organization (WIPO) WO2016039408 2034-09-11   Start Trial
Nitrazepam World Intellectual Property Organization (WIPO) WO2016085784 2034-11-26   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Johnson and Johnson
Boehringer Ingelheim
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.